|
Volumn 55, Issue 7, 2010, Pages 1250-1251
|
Outpatient high-dose methotrexate: Proceed with extreme caution, if at all
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
DOXORUBICIN;
METHOTREXATE;
ALLERGIC DISEASE;
ASPERGILLOSIS;
CANCER CHEMOTHERAPY;
CANCER PATIENT;
CLINICAL TRIAL;
CONSTIPATION;
COST CONTROL;
DRUG COST;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
FEVER;
HOME CARE;
HOSPITAL CARE;
HOSPITAL DISCHARGE;
HOSPITALIZATION;
HUMAN;
LOW DRUG DOSE;
LYMPHATIC LEUKEMIA;
LYMPHOMA;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUROLOGICAL COMPLICATION;
NEUTROPENIA;
NOTE;
OSTEOSARCOMA;
OUTPATIENT;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK FACTOR;
THROMBOCYTOPENIA;
AMBULATORY CARE;
ANTIMETABOLITES, ANTINEOPLASTIC;
BONE NEOPLASMS;
CHILD;
HUMANS;
METHOTREXATE;
OSTEOSARCOMA;
|
EID: 78049314268
PISSN: 15455009
EISSN: 15455017
Source Type: Journal
DOI: 10.1002/pbc.22847 Document Type: Note |
Times cited : (2)
|
References (7)
|